Key facts
- It has raised $5.0M; the latest was Seed Round ($5.0M) in Jul 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Tomoverse Imaging
- ·The full record, as it builds
Funding rounds
No funding rounds for Tomoverse Imaging are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tomoverse Imaging
Developer of cardiac CT imaging software designed to assist in structural heart and coronary intervention planning. The company offers cloud-based tools with real-time image analysis, customizable interfaces, advanced volume rendering, and AI-powered automation for procedural planning and education, enabling interventional cardiologists to improve clinical workflows and patient outcomes through faster, more accurate decision-making.
- Sector
- Healthcare
- HQ
- Dollard-Des Ormeaux, Canada
- Founded
- 2022
- Employees
- 6
- Website
- tomoverse.tech/
- Ownership
- Privately Held (backing)
Tomoverse Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tomoverse Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tomoverse Imaging in its N-PORT filings yet. We sweep new filings monthly.